Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection
Clinical trial NCT04856085 · COMPLETED
Trial details
- NCT number
- NCT04856085
- Sponsor
- Vir Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-11
- Primary completion
- 2026-03-16
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.